Mary Akosile, MS, MPH

Akosile_Mary_A_205x293.jpg

“I apply well-established and innovative statistical methods to clinical and public health research. My objective is to support, challenge, or capture new findings that influence decisions that can improve health and health care, worldwide."

Mary Akosile, MS, MPH

Biostatistician, Kaiser Permanente Washington Health Research Institute

Mary.A.Akosile@kp.org
206-287-2893

Biography

Biostatistician Mary Akosile, MPH, MS, is interested in research that investigates the effectiveness and efficacy of treatment in pharmacoepidemiologic studies. She has a broad range of interest in research with a strong motivation to investigate the health challenges of malaria, obesity, cancer, heart disease, and maternal health.

Ms. Akosile began her contributions to clinical and public health research through her academic training at the University of Texas Health Science Center, School of Public Health. She further got rigorous research experience by being a part of the leukemia, lymphoma, and cancer prevention research team at The University of Texas M.D. Anderson Cancer Center in 2015. She is now a biostatistician at Kaiser Permanente Washington Health Research Institute's Biostatistics Unit since 2018.

Ms. Akosile looks forward to using her expertise in application of epidemiological principles and surveillance methodologies at KPWHRI. She has an in-depth knowledge of the ICH-GCP, FDA, IRB policies, regulations, and guidelines and plans to use her skills and background to implement epidemiologic study designs in clinical research studies.

Research interests and experience

  • Biostatistics

  • Mental Health

  • Women's Health

  • Cancer

    Efficacy and safety of therapies; association between genetic variability and survival outcomes

  • Obesity 

    Role of nutritional, psychological and lifestyle factors; obesity prevention and control

  • Cardiovascular Health

  • Social Determinants of Health

  • Vaccines & Infectious Diseases

  • Heart Disease

    Role of aging, nutritional and lifestyle factors; Intervention strategies for prevention and disease control

  • Maternal Health

    Association between social, behavioral and clinical factors and maternal and infant outcomes

  • Malaria

    Malaria prevention and control; development of vaccines; availability and accessibility to malaria treatment

  •  

 

Recent publications

Akosile M, Pierce S, Brandt M, Verstovsek S, Borthakur G, Kantarjian H, Ravandi F, Wierda W, Garcia-Manero G, Daver N, Kadia T, Burger JA, Pemmaraju N, Jabbour E, Cortes J. Survival impact of patients (pts) with chronic myeloid leukemia (CML) due to failure from the use of one or more tyrosine kinase inhibitors (TKI). Blood, 126(23), 1587. Accessed December 11, 2017. Retrieved from http://www.bloodjournal.org/content/126/23/1587.

Boddu P, Garcia-Manero G, Ravandi F, Borthakur G, Jabbour E, DiNardo C, Jain N, Daver N, Pemmaraju N, Anderlini P, Parmar S, Kc D, Akosile M, Pierce SA, Champlin R, Cortes J, Kantarjian H, Kadia T. Clinical outcomes in adult patients with aplastic anemia: a single institution experience Am J Hematol. 2017 Dec;92(12):1295-1302. doi: 10.1002/ajh.24897. Epub 2017 Sep 25. PubMed

Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, Orlowski RZ, Neelapu S, Boddu PC, Akosile MA, Uldrick TS, Yarchoan R, Medeiros LJ, Li Y, Fajgenbaum DC, Young KH. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood. 2017 Mar 23;129(12):1658-1668. doi: 10.1182/blood-2016-11-748855. Epub 2017 Jan 18. PubMed

 

video

Video_thumbnail-Arterburn-Diabetes_1_column.jpg

Bariatric Surgery linked to fewer complications from diabetes

Sep 2018

KPWHRI’s Dr. David Arterburn and Dr. Rebecca O’Brien, Kaiser Permanente Northern California, talk about results from their recent study. (YouTube, 1:48)

cancer research

SusanKarenDianneMary-1col.jpg

Using breast MRI after cancer may lead to unneeded biopsies

A Kaiser Permanente-led BCSC study is among the largest ever to evaluate adding MRI surveillance for breast cancer survivors.